Skip to main content
COO
NASDAQ Life Sciences

Cooper Companies Tops Q2 Adjusted EPS and Revenue Estimates

Reported by Reuters
Sentiment info
Positive
Importance info
8
Price
$62.21
Mkt Cap
$12.101B
52W Low
$58.89
52W High
$89.83
Market data snapshot near publication time

Summary

The Cooper Companies reported Q2 adjusted EPS of $1.21, beating analyst estimates of $1.10. Revenue also exceeded expectations at $1,082 million against an estimated $1,054 million. This continues a trend of strong top-line performance seen in Q1. However, the company recorded a GAAP EPS loss of $0.40 and a negative EBIT margin of -3%, highlighting a divergence between adjusted and GAAP profitability.

At the time of this announcement, COO was trading at $62.21 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $12.1B. The 52-week trading range was $58.89 to $89.83. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

COO - Latest Insights

COO
Jun 04, 2026, 4:27 PM EDT
Filing Type: 8-K
Importance Score:
8
COO
Jun 04, 2026, 4:16 PM EDT
Source: Reuters
Importance Score:
8
COO
May 04, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
7
COO
Mar 06, 2026, 4:12 PM EST
Filing Type: 10-Q
Importance Score:
8
COO
Mar 05, 2026, 4:38 PM EST
Source: Reuters
Importance Score:
8
COO
Mar 05, 2026, 4:27 PM EST
Filing Type: 8-K
Importance Score:
8
COO
Feb 24, 2026, 4:19 PM EST
Filing Type: DEF 14A
Importance Score:
8
COO
Feb 03, 2026, 9:58 PM EST
Filing Type: 8-K
Importance Score:
8